bpc-157 pilot study interstitial cystitis as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Interstitial Cystitis / GLX-100 -
Interstitial Cystitis GLX 100 Glycologix Risk Classification for Interstitial Cystitis Bladder Pain Syndrome Using Machine Learning Based Predictions ScienceDirect The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome This doesn't mean BPC 157 is side effect free. But it does add to the safety signal. Credit to @dr.kseniamiami for mentioning this study on our recent podcast recording last week which will be out
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


